These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1020 related items for PubMed ID: 31672964

  • 1. Theabrownin from Pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism.
    Huang F, Zheng X, Ma X, Jiang R, Zhou W, Zhou S, Zhang Y, Lei S, Wang S, Kuang J, Han X, Wei M, You Y, Li M, Li Y, Liang D, Liu J, Chen T, Yan C, Wei R, Rajani C, Shen C, Xie G, Bian Z, Li H, Zhao A, Jia W.
    Nat Commun; 2019 Oct 31; 10(1):4971. PubMed ID: 31672964
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Hepatic cholesterol accumulation ascribed to the activation of ileum Fxr-Fgf15 pathway inhibiting hepatic Cyp7a1 in high-fat diet-induced obesity rats.
    Duan Y, Zhang F, Yuan W, Wei Y, Wei M, Zhou Y, Yang Y, Chang Y, Wu X.
    Life Sci; 2019 Sep 01; 232():116638. PubMed ID: 31288013
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Lysimachia christinae polysaccharide attenuates diet-induced hyperlipidemia via modulating gut microbes-mediated FXR-FGF15 signaling pathway.
    Zhou YF, Nie J, Shi C, Zheng WW, Ning K, Kang J, Sun JX, Cong X, Xie Q, Xiang H.
    Int J Biol Macromol; 2023 Sep 01; 248():125725. PubMed ID: 37419267
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pu-erh tea and theabrownin ameliorate metabolic syndrome in mice via potential microbiota-gut-liver-brain interactions.
    Hou Y, Zhang Z, Cui Y, Peng C, Fan Y, Tan C, Wang Q, Liu Z, Gong J.
    Food Res Int; 2022 Dec 01; 162(Pt B):112176. PubMed ID: 36461373
    [Abstract] [Full Text] [Related]

  • 9. L-Theanine regulates lipid metabolism by modulating gut microbiota and bile acid metabolism.
    Xu W, Kong Y, Zhang T, Gong Z, Xiao W.
    J Sci Food Agric; 2023 Feb 01; 103(3):1283-1293. PubMed ID: 36087337
    [Abstract] [Full Text] [Related]

  • 10. Probiotic Lactobacillus rhamnosus GG Prevents Liver Fibrosis Through Inhibiting Hepatic Bile Acid Synthesis and Enhancing Bile Acid Excretion in Mice.
    Liu Y, Chen K, Li F, Gu Z, Liu Q, He L, Shao T, Song Q, Zhu F, Zhang L, Jiang M, Zhou Y, Barve S, Zhang X, McClain CJ, Feng W.
    Hepatology; 2020 Jun 01; 71(6):2050-2066. PubMed ID: 31571251
    [Abstract] [Full Text] [Related]

  • 11. Cholesterol-lowering effects of taurine through the reduction of ileal FXR signaling due to the alteration of ileal bile acid composition.
    Miyata M, Tanaka T, Takahashi K, Funaki A, Sugiura Y.
    Amino Acids; 2021 Oct 01; 53(10):1523-1532. PubMed ID: 34596761
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mitigation of high-fat diet-induced hepatic steatosis by thyme (Thymus quinquecostatus Celak) polyphenol-rich extract (TPE): insights into gut microbiota modulation and bile acid metabolism.
    Sheng X, Zhan P, Wang P, He W, Tian H.
    Food Funct; 2024 Jul 15; 15(14):7333-7347. PubMed ID: 38305590
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Lactoferrin promotes bile acid metabolism and reduces hepatic cholesterol deposition by inhibiting the farnesoid X receptor (FXR)-mediated enterohepatic axis.
    Ling CJ, Xu JY, Li YH, Tong X, Yang HH, Yang J, Yuan LX, Qin LQ.
    Food Funct; 2019 Nov 01; 10(11):7299-7307. PubMed ID: 31626262
    [Abstract] [Full Text] [Related]

  • 18. Astragaloside IV ameliorates diet-induced hepatic steatosis in obese mice by inhibiting intestinal FXR via intestinal flora remodeling.
    Zhai Y, Zhou W, Yan X, Qiao Y, Guan L, Zhang Z, Liu H, Jiang J, Liu J, Peng L.
    Phytomedicine; 2022 Dec 01; 107():154444. PubMed ID: 36155217
    [Abstract] [Full Text] [Related]

  • 19. Phosphorylation of hepatic farnesoid X receptor by FGF19 signaling-activated Src maintains cholesterol levels and protects from atherosclerosis.
    Byun S, Jung H, Chen J, Kim YC, Kim DH, Kong B, Guo G, Kemper B, Kemper JK.
    J Biol Chem; 2019 May 31; 294(22):8732-8744. PubMed ID: 30996006
    [Abstract] [Full Text] [Related]

  • 20. Impaired Intestinal Farnesoid X Receptor Signaling in Cystic Fibrosis Mice.
    Ikpa PT, Doktorova M, Meijsen KF, Nieuwenhuijze NDA, Verkade HJ, Jonker JW, de Jonge HR, Bijvelds MJC.
    Cell Mol Gastroenterol Hepatol; 2020 May 31; 9(1):47-60. PubMed ID: 31470114
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.